Showing results: 1 - 9 of 9 items found.
-
LXinstruments GmbH
VXI-based functional test system for testing implantable medical electronic products. The system is equipped with a Virginia Panel Series 90 adapter interface and can be operated standalone as well as on handling systems. Based on the previously developed matrix-based standard architecture, a large number of systems were supplied. The system function can be verified at any time via an automated self-test.
-
EXPMT 2000 -
Netech Corp.
The EXPMT 2000 External Pacemaker Analyzer tests and verifies all the functions of any external pacemaker including transvenous, transcutanious (transthoracic), and Atrial and Ventricular sequential pacemakers.
-
Fluke Biomedical
Fluke Biomedical’s defibrillator analyzers and defibrillator/transcutaneous pacemaker testing devices are rugged, portable precision test instruments that ensure proper operation and ultimate performance of critical life-support cardiac-resuscitation equipment. We offer best-in-class defibrillator testers that feature capabilities which encompass a wide spectrum of worldwide established pulse shapes, showcasing AED tester compatibility, and outperforming competitors in accuracy and standards.
-
Holland Shielding Systems B.V.
On site testing for exposure limits in working conditions to any international standard. This involve pacemakers and HSE Heath and safety executive, invitarisations worldwide.
-
Radiometrics Midwest Corporation
Radiometrics personnel will come to you and perform site surveys to help in the mitigation of interference or to determine if the environment contains any sources that may interfere with an individuals implanted device such as pacemakers, defibrillators, nerve stimulators, etc.
-
TA Instruments
From bare metal stents to heart valves to pacemaker components, we offer the most comprehensive portfolio of cardiovascular device testing solutions. For more than 20 years, medical device manufacturers have trusted ElectroForce as the world leader in accelerated fatigue test instruments.
-
GS-X -
S.P.L. Elektronik
The GS-X Testing System consists of a Basic Unit and various plug-in test modules which the user can purchase as required. The range of functions of these Module-Box is being continuously expanded, and presently includes functions for testing the following devices: - Infusion pumps, Cardiac pacemakers, Defibrillators, High-frequency Surgical equipment, electrical safety ECG Simulation, Equipment for electro-stimulation.
-
N6781A -
Keysight Technologies
The Keysight N6781A is a source / measure unit (SMU) designed specifically for the task of battery drain analysis. Whether the device under test (DUT) is an eBook reader, MP3 player, mobile phone, or pacemaker, the N6781A’s seamless measurement ranging, programmable output resistance, and auxiliary DVM combine the best set of advanced features on the market for battery drain analysis. When used with the 14585A Control and Analysis software, the N6781A becomes an even more powerful battery drain analysis solution, offering additional insights into your measurements. Learn more about the 14585A Control and Analysis software.
-
Keystone Compliance
An EMI site survey is an independent assessment of the potential Electromagnetic Interference (EMI) risks that might interfere with an implantable electrical device such as a pacemaker or defibrillator. The assessment should be completed by a qualified and accredited independent test lab such as Keystone Compliance and in collaboration with the employer, manufacturer of the device, patient and physician. A site survey is conducted by taking various electromagnetic measurements throughout the facility. Keystone Compliance uses a broad range of industry-accepted standards and specifications to determine which electromagnetic fields exist. Following completion of the on-site survey, Keystone Compliance provides the customers with a detailed site survey report that will help identify EMI sources and zones with the potential to interact with an implantable electrical device. This information should then be shared with the physician and employer to develop an action plan to reduce potential negative effects to the patient’s health.
